Michelle Wiest, most recently vice president of pharmacy services at UC Health in Cincinnati, is Apexus’s new senior vice president of 340B policy and compliance.
Apexus announced Wiest’s hiring yesterday. The company said Wiest will oversee its education programming, compliance
…
Health care services and group purchasing company Vizient asked Congress on Monday to pass the U.S. Senate version of bipartisan legislation to protect hospitals from losing their 340B eligibility due to changes in patient and payer mix caused by the
…Boston-based par8o, which provides 340B services including a platform to help 340B covered entities manage their patient referral claims, has been acquired by Cloudmed.
Cloudmed is a revenue intelligence company based in Atlanta. The company partners with over 3,100 healthcare
…
Pharmacy automation, 340B compliance, and medication management company Omnicell is acquiring ReCept Holdings, which helps hospitals, health centers, Ryan White Clinics, and other providers open and manage in-house 340B pharmacies and specialty pharmacies.
Mountain View, Calif.-based Omnicell (a 340B Report
…
Kaiser Health News (KHN), a nonprofit health care news organization whose stories are widely and freely republished and rebroadcast, released an in-depth article and news video today about the 340B program and the fight over 340B contract pharmacy.
According to
…
Sectyr, an established provider of compliance platforms for 340B covered entities, has acquired LicenseTrak, a system for managing license, contract, training, and other business tasks, the companies announced last week.
Scottsdale, Ariz.-based Sectyr will fold Bloomington, Minn.-based LicenseTrak into its
…
After an initial burst of optimism earlier this year, some health care organizations are having second thoughts about large in-person events for the remainder of 2021 and the start of the new year. However, some groups including the 340B Coalition
…
In his latest column for Omnicell, 340B Report Publisher and CEO Ted Slafsky ponders four burning questions as we approach the first anniversary of drug manufacturers stopping or placing restrictions on 340B drug discounts in the contract pharmacy setting.
The American Hospital Association (AHA) told pharmacy benefit manager Express Scripts (ESI) this week its new 340B claims identification requirement for covered entities and their contract pharmacies “is a major overreach” and should be withdrawn immediately.
An ESI spokesperson was
…
*Sign up for news summaries and alerts from 340B Report